The 2024 MIT Health Science Technology Conference will highlight broad and transformative trends in biology and healthcare, including early-stage discovery, immune cell responses, diagnostics, clinical capabilities, process development, rapid and continuous manufacturing, robotics and automation, and sustainability, all enhanced by artificial intelligence and machine learning technologies. Leading MIT researchers and MIT-connected startups will showcase these advances and discuss their implications for improving human health.
P&G and AS Watson are looking for startup partnerships to build new, personalized, effortless, and cost-effective ways to enhance the overall shopper experience Online + Offline through the Guided Selling Challenge and the Social Commerce Challenge.
P&G wants to further develop their strategic framework for AI-Powered Brand Building to identify opportunities to step change the business. Areas of interest include consumer insights, campaign development, content creation & adaptation across touchpoints (messaging, image, video, animation etc.), Gen AI Brand Visibility and Agentic AI applications across the consumer journey. Deadline for applications is December 31, 2025.
xTechIgnite is a competition for eligible small businesses across the U.S. to engage with the Department of Defense (DoD), earn prize money and submit a Phase I or Direct to Phase II (D2PhII) Army Small Business Innovation Research (SBIR) proposal.
"Trends in Wellness Investments", David T. Thibodeau, Managing Director, Wellvest Capital
"Slowing the aging process of aging by tweaking the body’s metabolism", Prof. Leonard P. Guarente, Novartis Professor of Biology, MIT & co-founder, Elysium Health
Startup Lightning Talks - 2022 MIT Health Science Technologies Conference: Innovations in Drug Discovery and Manufacturing
P&G is looking for new technology-enabled solutions, services and business models that incentivize and drive lasting behavior change.